Angiotensin II inhibitors with thiazides

TEVA 7615 Pill - yellow round, 8mm

Pill with imprint TEVA 7615 is Yellow, Round and has been identified as Hydrochlorothiazide and Olmesartan Medoxomil 12.5 mg / 20 mg. It is supplied by Teva Pharmaceuticals USA, Inc.

Hydrochlorothiazide/olmesartan is used in the treatment of High Blood Pressure and belongs to the drug class angiotensin II inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/olmesartan 12.5 mg / 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Hydrochlorothiazide and olmesartan (Hydrochlorothiazide and olmesartan [ hye-droe-klor-oh-thye-a-zide-and-ol-me-sar-tan ])-TEVA 7615-12.5 mg / 20 mg-Yellow-Round

Hydrochlorothiazide and olmesartan
Generic Name: hydrochlorothiazide and olmesartan [ hye-droe-klor-oh-thye-a-zide-and-ol-me-sar-tan ]
Imprint: TEVA 7615
Strength: 12.5 mg / 20 mg
Color: Yellow
Size: 8.00 mm
Shape: Round
Availability: Prescription only
Drug Class: Angiotensin II inhibitors with thiazides
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00093-7615 (Discontinued)
Inactive Ingredients: Ferrosoferric oxide, Ferric oxide red, Ferric oxide yellow, Lactose monohydrate, Magnesium stearate, Microcrystalline cellulose, Polyethylene glycol 3350, Polyethylene glycol 4000, Sodium lauryl sulfate, Magnesium silicate, Titanium dioxide,
Latest News
Related Drugs